CXCL12 and hepatocellular carcinoma: Cheng et al. reported that CAFs in hepatocellular carcinoma (HCC) attracted neutrophils through the CXCL12/CXCR4 pathway and sustained their survival and activation via IL-6-induced JAK-STAT3 signaling [168].